10XREVIV Launch Announced in Abu Dhabi Through Partnership Between 10X Health, REVIV Global and M42
Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity
Ascletis selects once-monthly SQ GLP-1R/GIPR dual peptide agonist, ASC35, for clinical development
Celltrion's biosimilar EYDENZELT (aflibercept-boav) approved by US FDA
Novo Nordisk to acquire Akero Therapeutics in USD5.2bn deal to strengthen MASH pipeline
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe